Skip to main content
Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · TERN ISIN · US8808811074 LEI · 254900S1ZDQMF4MYP709 US Professional, scientific and technical activities
Filings indexed 406 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country US United States of America
Listing US TERN

About Terns Pharmaceuticals, Inc.

https://ternspharma.com/

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops a portfolio of small-molecule product candidates for serious diseases, with a focus on oncology and obesity. The company's strategy is to innovate upon de-risked, clinically validated mechanisms of action to create therapies with superior efficacy, safety, and convenience profiles. Its lead product candidate, TERN-701, is an oral, allosteric BCR-ABL inhibitor in development for the treatment of chronic myeloid leukemia (CML). Terns aims to address significant unmet medical needs by improving upon existing treatments.

Recent filings

Filing Released Lang Actions
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English
S-8 POS - Terns Pharmaceuticals, Inc. (0001831363) (Filer)
Regulatory Filings
2026-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.